Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US Stock Movement | CrowdStrike drops over 1% pre-market as Q1 earnings miss expectations

US Stock Movement | CrowdStrike drops over 1% pre-market as Q1 earnings miss expectations

格隆汇格隆汇2026/06/05 09:44
Show original
```htmlGolden Globe June 5|CrowdStrike (CRWD.US), which closed down 3.81% yesterday, continued to fall 1.66% in today's U.S. pre-market to $707.171. In terms of news, UBS analysts noted in a research report that CrowdStrike's first quarter performance fell short of expectations. With net new annual recurring revenue at $256 million, below investor expectations, analysts pointed out that "the 2% beat is much lower than the steady pace of 10%+ in previous quarters." The analysts believe that from now on, the main debate will revolve around the future 'beat pace.' (Golden Globe)```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage